Patents by Inventor Roy Chung
Roy Chung has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 9547015Abstract: Provided herein are compositions, kits, methods and devices for cyanide detection, particularly for cyanide detection in biological samples such as whole blood. The method comprises (1) contacting a sample with a cobinamide conjugate comprising a cobinamide moiety and a carrier; and (2) measuring the absorbance of light by the cobinamide conjugate. The present disclosure provides field-deployable cyanide detection methods, compositions, kits and devices, which provide rapid, accurate readout at the point of contact. Further provided herein is a method for determining exposure of a subject to cyanide.Type: GrantFiled: July 7, 2015Date of Patent: January 17, 2017Assignee: DIAGNOSTIC CONSULTING NETWORK, INC.Inventors: Brendan O'Farrell, Hans Boehringer, Roy Chung, Winnie Tong
-
Publication number: 20150309056Abstract: Provided herein are compositions, kits, methods and devices for cyanide detection, particularly for cyanide detection in biological samples such as whole blood. The method comprises (1) contacting a sample with a cobinamide conjugate comprising a cobinamide moiety and a carrier; and (2) measuring the absorbance of light by the cobinamide conjugate. The present disclosure provides field-deployable cyanide detection methods, compositions, kits and devices, which provide rapid, accurate readout at the point of contact. Further provided herein is a method for determining exposure of a subject to cyanide.Type: ApplicationFiled: July 7, 2015Publication date: October 29, 2015Applicant: DIAGNOSTIC CONSULTING NETWORK, INC.Inventors: Brendan O'FARRELL, Hans BOEHRINGER, Roy CHUNG, Winnie TONG
-
Patent number: 9110029Abstract: Provided herein are compositions, kits, methods and devices for cyanide detection, particularly for cyanide detection in biological samples such as whole blood. The method comprises (1) contacting a sample with a cobinamide conjugate comprising a cobinamide moiety and a carrier; and (2) measuring the absorbance of light by the cobinamide conjugate. The present disclosure provides field-deployable cyanide detection methods, compositions, kits and devices, which provide rapid, accurate readout at the point of contact. Further provided herein is a method for determining exposure of a subject to cyanide.Type: GrantFiled: March 14, 2013Date of Patent: August 18, 2015Assignee: Diagnostic Consulting Network, Inc.Inventors: Brendan O'Farrell, Hans Boehringer, Roy Chung, Winnie Tong
-
Publication number: 20130344620Abstract: Provided herein are compositions, kits, methods and devices for cyanide detection, particularly for cyanide detection in biological samples such as whole blood. The method comprises (1) contacting a sample with a cobinamide conjugate comprising a cobinamide moiety and a carrier; and (2) measuring the absorbance of light by the cobinamide conjugate. The present disclosure provides field-deployable cyanide detection methods, compositions, kits and devices, which provide rapid, accurate readout at the point of contact. Further provided herein is a method for determining exposure of a subject to cyanide.Type: ApplicationFiled: March 14, 2013Publication date: December 26, 2013Applicant: Diagnostic Consulting Network, Inc.Inventors: Brendan O'FARRELL, Hans BOEHRINGER, Roy CHUNG, Winnie TONG
-
Patent number: 7297554Abstract: A competitive immunoassay, dye and method for rapidly detecting the presence of one or more target ligands within a fluid sample suspected of containing such ligand or ligands. The immunoassay comprises a protein-binding membrane, a first absorbent pad, a second absorbent pad, and a third absorbent pad. The protein-binding membrane has at least two regions of antibodies bound thereto for detecting dissimilar ligands. The second absorbent pad has formed therein a colloidal gold tracer having one, and preferably two or more ligand analog protein complexes adhering thereto. To utilize the system, the immunoassay strip is placed within a fluid sample. To the extent the target ligand is absent, a visual indicator will be provided signaling such absence. To the extent the target ligand is present at or above a threshold level, no such visual signal will be produced.Type: GrantFiled: October 28, 2003Date of Patent: November 20, 2007Assignee: Microdiagnostics, Inc.Inventors: Roy Chung, June Shozi
-
Publication number: 20040087036Abstract: A competitive immunoassay, dye and method for rapidly detecting the presence of one or more target ligands within a fluid sample suspected of containing such ligand or ligands. The immunoassay comprises a protein-binding membrane, a first absorbent pad, a second absorbent pad, and a third absorbent pad. The protein-binding membrane has at least two regions of antibodies bound thereto for detecting dissimilar ligands. The second absorbent pad has formed therein a colloidal gold tracer having one, and preferably two or more ligand analog protein complexes adhering thereto. To utilize the system, the immunoassay strip is placed within a fluid sample. To the extent the target ligand is absent, a visual indicator will be provided signaling such absence. To the extent the target ligand is present at or above a threshold level, no such visual signal will be produced.Type: ApplicationFiled: October 28, 2003Publication date: May 6, 2004Inventors: Roy Chung, June Shozi
-
Publication number: 20010026944Abstract: A competitive immunoassay and method for rapidly detecting the presence of one or more target ligands within a fluid sample suspected of containing such ligand or ligands. According to a preferred embodiment, the immunoassay comprises an elongate adhesive-coated plastic support onto which are formed a protein-binding membrane, a first absorbent pad, a second absorbent pad, and a third absorbent pad. The protein-binding membrane has two regions of antibodies bound thereto, one antibody being specific to the target ligand, and the other as a test control. The second absorbent pad comprises a high capacity absorbent having formed therein a freeze-dried colloidal gold tracer, and may further include a control reagent for binding with the test control antibodies. To utilize the system, the immunoassay strip is placed within a fluid sample. To the extent the target ligand is absent, a visual indicator will be provided signalling such absence.Type: ApplicationFiled: March 20, 2001Publication date: October 4, 2001Inventors: Roy Chung, June Shozi
-
Patent number: D303171Type: GrantFiled: April 3, 1986Date of Patent: August 29, 1989Assignee: Bissell Inc.Inventors: Gordon W. Goodrich, Roy Chung